Abstract
The provision of psychiatric treatment via live interactive videoconferencing, frequently termed telepsychiatry, is a viable option for psychiatrists to provide care to individual patients, populations, and communities faced with limited access and to move the point of care delivery into patients' living environments. Psychiatric providers new to videoconferencing should not be intimidated by the technology or its encompassing logistics, but they do need to develop an awareness of the salient regulatory, administrative, and clinical issues that arise in the practice of videoconferencing-based telepsychiatry. This article provides an overview of the current evidence base in telepsychiatry and reviews administrative and clinical issues in videoconferencing-based treatment. These points are then highlighted in a case example.
MeSH terms
-
Adrenergic alpha-1 Receptor Antagonists / therapeutic use
-
Adult
-
Antidepressive Agents / therapeutic use
-
Appointments and Schedules
-
Cooperative Behavior
-
Delivery of Health Care / methods*
-
Delivery of Health Care / organization & administration
-
Diagnosis, Differential
-
Drug Therapy, Combination
-
Evidence-Based Medicine
-
Family Therapy / methods
-
Female
-
Follow-Up Studies
-
Humans
-
Interdisciplinary Communication
-
Life Change Events
-
Patient Care Team / organization & administration
-
Prazosin / therapeutic use
-
Primary Health Care / methods
-
Primary Health Care / organization & administration
-
Psychiatry / methods*
-
Psychiatry / organization & administration
-
Remote Consultation / methods*
-
Rural Health
-
Sertraline / therapeutic use
-
Social Work, Psychiatric / methods
-
Social Work, Psychiatric / organization & administration
-
Stress Disorders, Post-Traumatic / diagnosis
-
Stress Disorders, Post-Traumatic / psychology
-
Stress Disorders, Post-Traumatic / therapy
-
Suicide, Attempted / prevention & control
-
Suicide, Attempted / psychology
-
Videoconferencing* / organization & administration
Substances
-
Adrenergic alpha-1 Receptor Antagonists
-
Antidepressive Agents
-
Sertraline
-
Prazosin